NCT00360698 - Insulin Glulisine in Type 2 Diabetic Patients | Biotech Hunter

Enrollment

106

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Insulin Glargine

One daily injection at bedtime

DRUG

Glimepiride

At same dosage as during the run-in period

DRUG

Insulin Glulisine

One bolus given before the main meal

DRUG

Metformin

At same dosage as during the run-in period

Trial Locations (3)

Sanofi-aventis, Bridgewater

Sanofi-Aventis, Moscow

Sanofi-aventis, Guildford